Clinical trial
Nitric Oxide (NO) Activity and Diabetic Nephropathy
NCT00136188 · University of Erlangen-Nürnberg Medical School, Other · Completed
Key facts
| NCT number | NCT00136188 |
|---|---|
| Title | Nitric Oxide (NO) Activity and Diabetic Nephropathy |
| Official title | Role of NO Activity for the Development of Diabetic Nephropathy |
| Lead sponsor | University of Erlangen-Nürnberg Medical School, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Nephropathies |
| Intervention type | Drug |
| Interventions | Folic Acid |
| Enrollment | 100 |
| Start date | Aug 1, 2009 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Aug 26, 2005 |
| Last update posted | Jun 19, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: